Stock Market News
Smiths Group in talks about merging medical division with ICU Medical
Smiths Group confirmed on Tuesday that it is in very early stage discussions about a potential combination of its medical division with Nasdaq-listed ICU Medial.
Responding to press speculation, the company added that it routinely reviews all options for its portfolio of businesses to maximise value for shareholders.
"There can be no certainty that a transaction will be concluded," it said.
RBC Capital Markets said: "We consider the talks a positive for the Smiths investment case, albeit with the caveat that no potential financial terms have been mooted and that the talks could still come to nothing. We feel that investor hopes regarding a major portfolio move had receded, so this will come as a positive surprise.
"We applauded some of the early portfolio reshaping brought about by the management team as the focus switched from 'break-up' to 'bulk-up'. However, the Smiths investment case was starting to appear somewhat lacking a catalyst, as it moved into the delivery phase."
Numis noted press speculation of a £2bn valuation for the medical unit of 11x EBIT which it said was "a very low ball figure" having considered a spin-off at least twice in the last decade at a similar or higher price.
"We note that ICU trades on a forward EBIT multiple of 26x making mid teen margins against Smiths Medical circa 20%. We see £3bn as a far more realistic starting point (EBIT 16x) for Smiths Medical.
"It is also an interesting time to consider such a deal given the recent investment made which management expect to start to deliver growth from H2 2018 (year to July) after five years of top line stagnation. A nil disposal premium merger may not prove overly attractive but no doubt this will increase interest from other parties once more, potentially including PE as previous."
At 0825 BST, the shares were up 3.9% to 1,786.50p.
Responding to press speculation, the company added that it routinely reviews all options for its portfolio of businesses to maximise value for shareholders.
"There can be no certainty that a transaction will be concluded," it said.
RBC Capital Markets said: "We consider the talks a positive for the Smiths investment case, albeit with the caveat that no potential financial terms have been mooted and that the talks could still come to nothing. We feel that investor hopes regarding a major portfolio move had receded, so this will come as a positive surprise.
"We applauded some of the early portfolio reshaping brought about by the management team as the focus switched from 'break-up' to 'bulk-up'. However, the Smiths investment case was starting to appear somewhat lacking a catalyst, as it moved into the delivery phase."
Numis noted press speculation of a £2bn valuation for the medical unit of 11x EBIT which it said was "a very low ball figure" having considered a spin-off at least twice in the last decade at a similar or higher price.
"We note that ICU trades on a forward EBIT multiple of 26x making mid teen margins against Smiths Medical circa 20%. We see £3bn as a far more realistic starting point (EBIT 16x) for Smiths Medical.
"It is also an interesting time to consider such a deal given the recent investment made which management expect to start to deliver growth from H2 2018 (year to July) after five years of top line stagnation. A nil disposal premium merger may not prove overly attractive but no doubt this will increase interest from other parties once more, potentially including PE as previous."
At 0825 BST, the shares were up 3.9% to 1,786.50p.
Related share prices |
---|
Smiths Group (SMIN) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price